Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document
This information will help sponsors comply with the Food and Drug Regulations (Regulations), with respect to comparative studies, with emphasis on in vivo comparative pharmacokinetic studies, used in support of the safety and efficacy of subsequent-entry orally inhaled drug products (OIPs).
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance DocumentHTMLEnglish publication HTML
-
Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance DocumentHTMLFrench publication HTML
Similar records